Ajanta Pharma Limited (NSE:AJANTPHARM)
India flag India · Delayed Price · Currency is INR
2,695.20
-56.20 (-2.04%)
Aug 1, 2025, 3:29 PM IST

Ajanta Pharma Statistics

Total Valuation

Ajanta Pharma has a market cap or net worth of INR 336.60 billion. The enterprise value is 330.97 billion.

Market Cap336.60B
Enterprise Value 330.97B

Important Dates

The last earnings date was Sunday, July 27, 2025.

Earnings Date Jul 27, 2025
Ex-Dividend Date Nov 6, 2024

Share Statistics

Ajanta Pharma has 124.89 million shares outstanding. The number of shares has decreased by -0.82% in one year.

Current Share Class 124.89M
Shares Outstanding 124.89M
Shares Change (YoY) -0.82%
Shares Change (QoQ) -0.13%
Owned by Insiders (%) 42.34%
Owned by Institutions (%) 20.84%
Float 41.84M

Valuation Ratios

The trailing PE ratio is 36.21 and the forward PE ratio is 31.42. Ajanta Pharma's PEG ratio is 2.86.

PE Ratio 36.21
Forward PE 31.42
PS Ratio 7.00
PB Ratio 8.88
P/TBV Ratio 8.99
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio 2.86
Financial Ratio History

Enterprise Valuation

EV / Earnings 35.59
EV / Sales 6.89
EV / EBITDA 25.37
EV / EBIT 28.35
EV / FCF n/a

Financial Position

Current Ratio n/a
Quick Ratio n/a
Debt / Equity 0.01
Debt / EBITDA 0.04
Debt / FCF n/a
Interest Coverage 46.21

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) n/a
Return on Invested Capital (ROIC) 19.60%
Return on Capital Employed (ROCE) n/a
Revenue Per Employee 4.99M
Profits Per Employee 965,891
Employee Count9,628
Asset Turnover n/a
Inventory Turnover n/a

Taxes

In the past 12 months, Ajanta Pharma has paid 2.68 billion in taxes.

Income Tax 2.68B
Effective Tax Rate 22.38%

Stock Price Statistics

The stock price has increased by +0.00% in the last 52 weeks. The beta is 0.18, so Ajanta Pharma's price volatility has been lower than the market average.

Beta (5Y) 0.18
52-Week Price Change +0.00%
50-Day Moving Average 2,639.29
200-Day Moving Average 2,737.64
Relative Strength Index (RSI) 48.88
Average Volume (20 Days) 158,337

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, Ajanta Pharma had revenue of INR 48.06 billion and earned 9.30 billion in profits. Earnings per share was 74.42.

Revenue48.06B
Gross Profit 36.55B
Operating Income 11.67B
Pretax Income 11.98B
Net Income 9.30B
EBITDA 12.92B
EBIT 11.67B
Earnings Per Share (EPS) 74.42
Full Income Statement

Balance Sheet

The company has 6.14 billion in cash and 509.20 million in debt, giving a net cash position of 5.63 billion or 45.07 per share.

Cash & Cash Equivalents 6.14B
Total Debt 509.20M
Net Cash 5.63B
Net Cash Per Share 45.07
Equity (Book Value) 37.90B
Book Value Per Share 301.59
Working Capital n/a
Full Balance Sheet

Cash Flow

Operating Cash Flow n/a
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 76.05%, with operating and profit margins of 24.29% and 19.35%.

Gross Margin 76.05%
Operating Margin 24.29%
Pretax Margin 24.93%
Profit Margin 19.35%
EBITDA Margin 26.89%
EBIT Margin 24.29%
FCF Margin n/a

Dividends & Yields

This stock pays an annual dividend of 28.00, which amounts to a dividend yield of 1.02%.

Dividend Per Share 28.00
Dividend Yield 1.02%
Dividend Growth (YoY) n/a
Years of Dividend Growth 3
Payout Ratio n/a
Buyback Yield 0.82%
Shareholder Yield 1.83%
Earnings Yield 2.76%
FCF Yield n/a
Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on June 22, 2022. It was a forward split with a ratio of 1.5.

Last Split Date Jun 22, 2022
Split Type Forward
Split Ratio 1.5

Scores

Altman Z-Score n/a
Piotroski F-Score 2